These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17620628)

  • 1. Combined molecular and clinical assessment of Plasmodium falciparum antimalarial drug resistance in the Lao People's Democratic Republic (Laos).
    Mayxay M; Nair S; Sudimack D; Imwong M; Tanomsing N; Pongvongsa T; Phompida S; Phetsouvanh R; White NJ; Anderson TJ; Newton PN
    Am J Trop Med Hyg; 2007 Jul; 77(1):36-43. PubMed ID: 17620628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
    Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
    Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
    Tessema SK; Kassa M; Kebede A; Mohammed H; Leta GT; Woyessa A; Guma GT; Petros B
    PLoS One; 2015; 10(10):e0126943. PubMed ID: 26431464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
    Pathak A; Mårtensson A; Gawariker S; Sharma A; Diwan V; Purohit M; Ursing J
    Malar J; 2020 Aug; 19(1):290. PubMed ID: 32795288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand.
    Kuesap J; Suphakhonchuwong N; Kalawong L; Khumchum N
    Korean J Parasitol; 2022 Apr; 60(2):109-116. PubMed ID: 35500892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations.
    Mayxay M; Newton PN; Khanthavong M; Tiengkham P; Phetsouvanh R; Phompida S; Brockman A; White NJ
    Clin Infect Dis; 2003 Oct; 37(8):1021-8. PubMed ID: 14523765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
    Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
    PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries.
    Srisutham S; Madmanee W; Kouhathong J; Sutawong K; Tripura R; Peto TJ; van der Pluijm RW; Callery JJ; Dysoley L; Mayxay M; Newton PN; Pongvongsa T; Hongvanthong B; Day NPJ; White NJ; Dondorp AM; Imwong M
    PLoS One; 2022; 17(12):e0278928. PubMed ID: 36525403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
    Chauvin P; Menard S; Iriart X; Nsango SE; Tchioffo MT; Abate L; Awono-Ambéné PH; Morlais I; Berry A
    J Antimicrob Chemother; 2015 Sep; 70(9):2566-71. PubMed ID: 26080363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016-2017.
    Rogier E; Herman C; Huber CS; Hamre KES; Pierre B; Mace KE; Présumé J; Mondélus G; Romilus I; Elismé T; Eisele TP; Druetz T; Existe A; Boncy J; Lemoine JF; Udhayakumar V; Chang MA
    Emerg Infect Dis; 2020 May; 26(5):902-909. PubMed ID: 32310062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
    Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR.
    Berens N; Schwoebel B; Jordan S; Vanisaveth V; Phetsouvanh R; Christophel EM; Phompida S; Jelinek T
    Trop Med Int Health; 2003 Sep; 8(9):775-82. PubMed ID: 12950663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.
    Nkoli Mandoko P; Rouvier F; Matendo Kakina L; Moke Mbongi D; Latour C; Losimba Likwela J; Ngoyi Mumba D; Bi Shamamba SK; Tamfum Muyembe JJ; Muepu Tshilolo L; Parzy D; Sinou V
    J Antimicrob Chemother; 2018 Oct; 73(10):2704-2715. PubMed ID: 30053021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of drug-resistant malaria in western Kenya highlands.
    Zhong D; Afrane Y; Githeko A; Cui L; Menge DM; Yan G
    BMC Infect Dis; 2008 Jul; 8():105. PubMed ID: 18671871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
    Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP
    Malar J; 2006 Jul; 5():54. PubMed ID: 16817953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.
    Menard D; Djalle D; Yapou F; Manirakiza A; Talarmin A
    Am J Trop Med Hyg; 2006 Feb; 74(2):205-10. PubMed ID: 16474071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
    Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.